Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice

European Journal of Neuroscience

Volumn 16, Issue 11, 2002, Pages 2231-2235

  Robbe, David ^a   Bockaert, Joël ^a   Manzoni, Olivier J ^a,b  

^a CNRS UPR 9023   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Addiction; LTD; mGlu2 3; Opiates; Synaptic plasticity

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EGLUMETAD; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; MORPHINE; OPIATE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SYNAPSE; VENTRAL TEGMENTUM;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; LONG-TERM DEPRESSION (PHYSIOLOGY); MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DEPENDENCE; NEURONS; NUCLEUS ACCUMBENS; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PURINERGIC P1; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036457114     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.02273.x     Document Type: Article

References (27)

1. Bonci, A. & Williams, J.T. (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron, 16, 631-639.
2. Brundege, J.M., Diao, L., Proctor, W.R. & Dunwiddie, T.V. (1997) The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology, 36, 1201-1210.
3. Brundege, J.M. & Williams, J.T. (2002) Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J. Neurophysiol., 87, 1369-1375.
4. Cartmell, J., Monn, J.A. & Schoepp, D.D. (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J. Pharmacol. Exp. Ther., 292, 161-170.
5. Cartmell, J., Monn, J.A. & Schoepp, D.D. (2000) The mGlu (2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. Eur. J. Pharmacol., 400, 221-224.
6. Chieng, B. & Williams, J.T. (1998) Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci., 18, 7033-7039.
7. Cornish, J.L., Duffy, P. & Kalivas, P.W. (1999) A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience, 93, 1359-1367.
8. Cornish, J.L. & Kalivas, P.W. (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci., 20, RC89.
9. De Vries, T.J. & Shippenberg, T.S. (2002) Neural systems underlying opiate addiction. J. Neurosci., 22, 3321.
10. Everitt, B.J. & Wolf, M.E. (2002) Psychomotor stimulant addiction: A neural systems perspective. J. Neurosci., 22, 3312-3315.
11. Fundytus, M.E. & Coderre, T.J. (1997) Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist. Br. J. Pharmacol., 121, 511-514.
12. Fundytus, M.E., Ritchie, J. & Coderre, T.J. (1997) Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br. J. Pharmacol., 120, 1015-1020.
13. Harrison, J.M., Allen, R.G., Pellegrino, M.J., Williams, J.T. & Manzoni, O.J. (2002) Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J. Neurophysiol., 87, 2464-2470.
14. Helton, D.R., Tizzano, Monn, J.P., Schoepp, D.D. & Kallman, M.J. (1997) LY354740: A metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology, 36, 1511-1516.
15. Ingram, S.L., Vaughan, C.W., Bagley, E.E., Connor, M. & Christie, M.J. (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci., 18, 10269-10276.
16. Kelley, A.E. & Berridge, K.C. (2002) The neuroscience of natural rewards: Relevance to addictive drugs. J. Neurosci., 22, 3306-3311.
17. Manzoni, O.J. & Williams, J.T. (1999) Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci., 19, 6629-6636.
18. Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nature Rev. Neurosci., 2, 119-128.
19. Pulvirenti, L., Maldonado-Lopez, R. & Koob, G.F. (1992) NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res., 594, 327-330.
20. Rassnick, S., Pulvirenti, L. & Koob, G.F. (1992) Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl.), 109, 92-98.
21. Robbe, D., Alonso, G., Chaumont, S., Bockaert, J. & Manzoni, O.J. (2002) Role of P/Q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses. J. Neurosci., 22, 4346-4356.
22. Rosenberg, P.A., Knowles, R., Knowles, K.P. & Li, Y. (1994) Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci., 14, 2953-2965.
23. Thomas, M.J., Beurrier, C., Bonci, A. & Malenka, R.C. (2001) Long-term depression in the nucleus accumbens: A neural correlate of behavioral sensitization to cocaine. Nature Neurosci., 4, 1217-1223.
24. Ungless, M.A., Whistler, J.L., Malenka, R.C. & Bonci, A. (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587.
25. Vandergriff, J. & Rasmussen, K. (1999) The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropharmacology, 38, 217-222.
26. White, F.J. (2002) A behavioral/systems approach to the neuroscience of drug addiction. J. Neurosci., 22, 3303-3305.
27. Williams, J.T., Christie, M.J. & Manzoni, O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev., 81, 299-343.